GGrantIndex
Sort

25,944 grants matching neurodegeneration

Novel Therapeutic Approaches to Increase Progranulin Levels in Brain to Treat FTD and AD

$3,112,016
Steven M Finkbeiner · J. David Gladstone Institutes · RF1 · FY2019 · AG

Developing Gyrencephalic Models of TBI-Induced ADRD Neuropathology

$3,102,638
Victoria Eleanor Johnson · University Of Pennsylvania · RF1 · FY2024 · NS

Indiana Alzheimer's Disease Research Center

$3,093,445
Andrew J Saykin · Indiana University Indianapolis · P30 · FY2021 · AG

The Role of RNA Binding Protein Networks in Tauopathy and Related Dementia

$3,090,198
Robert J Vassar · Northwestern University At Chicago · RF1 · FY2020 · AG

Deciphering the role of CX3CR1 in Modulating Mechanisms of Amyloid driven Neurodegeneration in Alzheimer's Disease

$3,087,997
Bruce T Lamb · Indiana University Indianapolis · RF1 · FY2020 · AG

Statistical Machine Learning to Develop Connectome-Based Biomarkers of Alzheimer's Disease and Related Dementias

$3,080,520
Ali Shojaie · University Of Washington · RF1 · FY2025 · AG

Cerebrovascular contributions to Alzheimer's disease in adults with Down Syndrome

$3,079,273
Adam M Brickman · Columbia University Health Sciences · RF1 · FY2022 · AG

Mechanism of stathmin-2-dependent axon maintenance, regeneration, and function

$3,072,075
Don W. Cleveland · University Of California, San Diego · R37 · FY2025 · NS

Procurement and Characterization of Postmortem Brain Tissue

$3,068,293
Karen Faith Berman · National Institute Of Mental Health · ZIC · FY2013 · MH

Proteinopathies of the Aging Central Nervous System

$3,051,367
Lennart Mucke · J. David Gladstone Institutes · P01 · FY2010 · AG

Indiana Alzheimer's Disease Research Center

$3,047,320
Andrew J Saykin · Indiana University Indianapolis · P30 · FY2022 · AG

Genetic and clinical studies of Gaucher disease and other lysosomal disorders

$3,047,164
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2021 · HG

Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive decline

$3,047,094
Thor Stein · Boston University Medical Campus · RF1 · FY2016 · AG

Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility

$3,039,783
Susan S Redline · Brigham And Women'S Hospital · R01 · FY2022 · AG

SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors

$3,039,032
Ananth V Annapragada · Baylor College Of Medicine · RF1 · FY2025 · NS

Proteinopathies of the Aging Central Nervous System

$3,028,460
Lennart Mucke · J. David Gladstone Institutes · P01 · FY2009 · AG

Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II

$3,019,032
Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS

South Texas Alzheimer's Disease Center

$3,014,460
Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2021 · AG

Investigating the Causal Role of Particulate Matter Components on Lewy Body Dementia: Integrating Epidemiologic and Mechanistic Evidence

$3,013,265
Robbie M Parks · Columbia University Health Sciences · RF1 · FY2025 · NS

Cell-type-specific neural circuit connectomes in the mouse models of aging and Alzheimer's disease

$3,012,295
Xiangmin Xu · University Of California-Irvine · U01 · FY2022 · AG

Escitalopram for Agitation in Alzheimer Disease

$3,011,794
Constantine G Lyketsos · Johns Hopkins University · R01 · FY2018 · AG

A temporal bioenergetic, metabolomics, and proteomic map of Alzheimer's disease in invertebrate models

$3,011,435
Gordon J. Lithgow · Buck Institute For Research On Aging · RF1 · FY2017 · AG

UCSD Alzheimer's Disease Research Center P50

$3,010,023
James B Brewer · University Of California, San Diego · P50 · FY2016 · AG

Mechanisms, modeling and therapies of retinal and macular neurodegeneration

$3,007,068
Anand Swaroop · National Eye Institute · ZIA · FY2022 · EY

Escitalopram for Agitation in Alzheimer Disease

$3,000,455
Constantine G Lyketsos · Johns Hopkins University · R01 · FY2017 · AG